Company Name: Aduro Biotech    

Aduro Biotech is a clinical stage cancer immunotherapy company. The company uses is proprietary live, attenuated, double-deleted (LADD) Listeria monocytogenes and cyclic dinucleotides (CDNs) platforms to develop immunotherapies for various cancers. The company’s lead product candidate is designed to target metastatic pancreatic cancer.

Ticker Symbol: ADRO (NASDAQ)

Company Website:

Social Media: Aduro BioTech LinkedIn

Headquarters: Berkeley, California